| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |